MoneyWorks4Me

Jubilant Pharmova informs about appointment of CEO

02 Dec 2025 Evaluate
Jubilant Pharmova has informed about the appointment of Daniel J. O’Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the Company. The company has enclosed the details. Date and Time of receipt - December 1, 2025, 08:00 PM (IST).

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..